Myelodysplastic Syndromes in Childhood—Classification, Epidemiology, and Treatment

References

• Lascari A.D. Preleukemia. Lascari A. D. Leukemia in childhood, A.D. Lascari. C. C. Thomas, Springfield 1973; 97–110
   Google Scholar
• Chessells J.M. Myelodysplasia. Baillière's Clin. Haematol. 1991; 4: 459–82
   PubMedGoogle Scholar
• Gadner H., Haas O.A. Experience in pediatric myelodysplastic syndromes. Hematol. Oncol. Clin. North Am. 1992; 6: 655–672
   PubMed Web of Science ®Google Scholar
• Hann I.M. Myelodysplastic syndromes. Arch Dis. Child. 1992; 67: 962–966
   PubMed Web of Science ®Google Scholar
• Niemeyer C., Stollmann-Gibbels B., Ebell W., Gaedicke G., Creutzig U. Myelodysplastische Erkrankungenim Kindesalter. Klin. Päiatr. 1992; 204: 190–197
   PubMed Web of Science ®Google Scholar
• Sommelet D., Buisine J. Myélodysplasies de I'enfant. Progrès en pédiatrie 7. Hématologie pédiatrique, D. Sommelet, G. Schaison. Doin Bditeurs, Paris, 174–202
   Google Scholar
• Wegelius R. Bone marrow dysfunctions preceding acute leukemia in children: a clinical study. Leuk. Res. 1992; 16: 71–76
   PubMed Web of Science ®Google Scholar
• Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. Proposals for the classification of the acute leukaemias. Br. J. Haematol. 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. Proposals for the classifications of the myelodysplastic syn dromes. Br. J. Haematol. 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Co operative Group. Ann. Intern. Med. 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Bain B.J. Leukemia Diagnosis. A guide to the FAB classification. J. B. Lippincott Company, Philadelphia 1990
   Google Scholar
• Third MIC Cooperative Study Group. Recommen dations for a morphologic, immunologic, and cytogenetic (MIC) working classification for the primary and therapy-related myelodysplastic disorders. Cancer Genet. Cytogenet. 1988; 32: 1–10
   PubMed Web of Science ®Google Scholar
• Tricot G.J. Prognostic factors in the myelodysplas tic syndromes. Leuk. Res. 1992; 16: 109–115
   PubMed Web of Science ®Google Scholar
• Kerndrup G., Bendix-Hansen K., Pedersen B., Ellegaard J., Hokland P. Analysis of leukocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia (RA) and RA with sideroblasts. Prognostic implications of sequential and follow-up data. Eur. J. Haematol. 1988; 41: 368–374
   PubMed Web of Science ®Google Scholar
• Heim S., Mitelman F. Themy elodysplastic syndromes, G.J. Mufti, D. A. G. Galton. Churchill Livingstone, Edinburgh 1992; 115–128
   Google Scholar
• Brandwein J.M., Horsman D.E., Eaves A.C., Eaves C.J., Massing B.G., Wadsworth L.D., et al. Childhood myelodysplasia: Suggested classification as my elodysplastic syndromes based on laboratory and clinical finding. Am. J. Pediatr. Hematol. Oncol. 1990; 12: 63–70
   PubMedGoogle Scholar
• Creutzig U., Cantfi-Rajnoldi A., Ritter J., Romitti L., Odenwald E., Conter V., et al. Myelodysplastic syndromes in childhood. Report of 21 patients from Italy and West Germany. Am. J. Pediatr. Hematol. Oncol. 1987; 9: 324–330
   PubMedGoogle Scholar
• Hasle H., Jacobsen B.B., Pedersen N.T. My elodysplastic syndromes in childhood: a population based study of nine cases. Br. J. Haematol. 1992; 81: 495–498
   PubMed Web of Science ®Google Scholar
• Tuncer M.A., Pagliuca A., Hicsonmez G., Yetgin S., Ozsoylu S., Mufti G.J. Primary myelodys plastic syndrome in children: the clinical experience in 33 cases. Br. J. Haematol. 1992; 82: 347–353
   PubMed Web of Science ®Google Scholar
• Fenaux P., Beuscart R., Lai J.L., Jouet J.P., Bau-Ters F. Prognostic factors in adult chronic myelo-monocytic leukemia: An analysis of 107 cases. J. Clin. On Col. 1988; 6: 1417–1424
   Google Scholar
• Solal-Celigny P., Desaint B., Herrera A., Chastang C., Amar M., Vroclans M., et al. Chronic myelomonocytic leukemia according to the FAB classification: Analysis of 35 cases. Blood 1984; 63: 634–638
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H., Schaison G., Passe S., Pasquier A., Berger R., Bayle-Weisgerber C., et al. Subacute and chronic myelomonocytic leukemia in children (Juvenile CML). Cancer 1984; 54: 675–686
   PubMed Web of Science ®Google Scholar
• Owen G., Lewis I.J., Morgan M., Robinson A., Stevens R.F. Prognostic factors in juvenile chronic granulocytic leukemia. Br. J. Cancer 1992; 66(Suppl. 18)S68–S71
   Google Scholar
• Bourantas K.L., Georgiou I., Seferiadis K. Quantitation of HBF gamma-chain types by HPLC in patients with myelodysplastic syndrome. Haematologica 1991; 76: 337–338
   PubMedGoogle Scholar
• Martiat P., Michaux J.L., Rodhain J. Ph-negative CML: Comparison with Ph+ CML and chronic myelomonocytic leukemia. Blood 1991; 78: 205–211
   PubMed Web of Science ®Google Scholar
• Kampmeier P., Anastasi J., Vardiman J.W. Issues in the pathology of the myelodysplastic syndromes. Hematol. Oncol. Clin. North Am. 1992; 6: 501–522
   PubMed Web of Science ®Google Scholar
• Bartl R., Frisch B., Baumgart R. Morphologic classification of the myelodysplastic syndromes (MDS): combined utilization of bone marrow aspirates and trephine biopsies. Leuk. Res. 1992; 16: 15–33
   PubMed Web of Science ®Google Scholar
• Mangi M.H., Mufti G.J. Primary myelodys plastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood 1992; 79: 198–205
   PubMed Web of Science ®Google Scholar
• Maschek H., Kaloutsi V., Rodriguez-Kaiser M., Werner M., Choritz H., Mainzer K., et al. Hypoplastic my elodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis. Ann. Hematol. 1993; 66: 117–122
   PubMed Web of Science ®Google Scholar
• Mansoor A.M., Bharadwaj T. P. R., Sethuraman S., Chandy M., Pushpa V., Kamada N., Murthy P. B. K. Analysis of karyotype, SCE, and point mutation of RAS oncogene in Indian MDS patients. Cancer Genet. Cytogenet 1993; 65: 12–20
   PubMed Web of Science ®Google Scholar
• Nair R., Athale U.A., Iyer R.S., Nair C.N., Pai S.K., Kurkure P.A., Kadam P.R., Advani S.H. Childhood myelodysplastic syndromes: clinical features, cytogenetics and prognosis. Indian J. Pediatr. 1992; 59: 443–448
   PubMedGoogle Scholar
• Fohlmeister I., Fischer R., Mödder B., Rister M., Schaefer H.-E. Aplastic anaemia and the hypocel-lular myelodysplastic syndrome: Histomorphological, diagnostic, and prognostic features. J. Clin. Pathol. 1985; 38: 1218–1224
   PubMed Web of Science ®Google Scholar
• Van Kamp H., Landegent J.E., Jansen R. P. M., Wil-Lemze R., Fibbe W.E. Clonal hematopoiesis in patients with acquired aplastic anemia. Blood 1991; 78: 3209–3214
   PubMed Web of Science ®Google Scholar
• Shinohara K., Yujiri T., Kamei S., Ayame H., Tanaka M., Ando S., Tajiri M. Absence of point mutation of N-rasoncogene in bone marrow cells with aplastic anemia. Int. J. Cell. Clon. 1992; 10: 94–98
   PubMedGoogle Scholar
• Lilleyman J.S. Bone marrow examination. Practical pediatric hematology, R.F. Hinchliffe, J.S. Lilleyman. John Wiley & Son, Chichester 1987; 47–79
   Google Scholar
• Williamson P.J., Oscier D.G., Bell A.J., Hamblin T.J. Red cell aplasia in myelodysplastic syndrome. J. Clin. Pathol. 1991; 44: 431–432
   PubMed Web of Science ®Google Scholar
• Dessypris E.N. Pure red cell aplasia. John Hopkins University Press, Baltimore 1988
   Google Scholar
• Najean Y., Lecompte T. Genetic thrombocy-topenia with autosomal transmission: a review of 54 cases. Br. J. Haematol. 1990; 74: 203–208
   PubMed Web of Science ®Google Scholar
• Olson T.A., Levine R.F., Kelleher J. Familial thrombocytopenia with micromegakaryocytes. Am. J. Pediatr. Hematol. Oncol. 1992; 14: 248–254
   PubMedGoogle Scholar
• Fenaux P., Estienne M.H., Lepelley P., Zandecki M., Lai J.L., Beuscart R., et al. Refractory anaemia according to the FAB classification: A report on 69 cases. Eur. J. Haematol. 1988; 40: 318–325
   PubMed Web of Science ®Google Scholar
• Menke D.M., Colon-Otero G., Cockerill K.J., Jenkins R.B., Noel P., Pierre R.V. Refractory throm-bocytopenia. A myelodysplastic syndrome that may mimic immune thrombocytopenic purpura. Am. J. Clin. Pathol. 1992; 98: 502–510
   PubMed Web of Science ®Google Scholar
• Hibbs J.R., Young N.S. Viruses and the blood. Baillière's Clin. Haematol. 1992; 5: 245–271
   PubMed Web of Science ®Google Scholar
• Rosenfeld S.J., Young N.S. Viruses and bone marrow failure. Blood Rev. 1991; 5: 71–77
   PubMed Web of Science ®Google Scholar
• Candido A., Rossi P., Menichella G., Pierelli L., Piz-Zigallo E., Camilli G., et al. Indicative morphological myelodysplastic alterations of bone marrow in overt AIDS. Haernatologica 1990; 75: 327–333
   PubMedGoogle Scholar
• Danova M., Riccardi A., Brugnatelli S., Maserati R., Comolli G., Mazzini G., et al. Bone marrow morphology and proliferative activity in acquired immunodeficiency syndrome. Haematologica 1989; 74: 365–369
   PubMedGoogle Scholar
• Karcher D.S., Frost A.R. The bone marrow in human immunodeficiency virus (HIV)-related disease. Am. J. Clin. Pathol. 1991; 95: 63–71
   PubMed Web of Science ®Google Scholar
• Schneider D.R., Picker L.J. Myelodysplasia in the acquired immune deficiency syndrome. Am. J. Clin. Pathol. 1985; 84: 144–152
   PubMed Web of Science ®Google Scholar
• Baurmann H., Schwarz T.F., Oertel J., Serke S., Rog-Gendorf M., Huhn D. Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow. Ann. Hematol. 1992; 64: 43–45
   PubMed Web of Science ®Google Scholar
• Herrod H.G., Dow L.W., Sullivan J.L. Persistent Epstein-Barr virus infection mimicking juvenile chronic myelogenous leukemia: Immunologic and hematologic studies. Blood 1983; 61: 1098–1104
   PubMed Web of Science ®Google Scholar
• Lutz P., Folléa G., Albert A., Falkenrodt A., Jung J.J., Masson E., Lévy J.M. Place de la greffe allogénique de moelle osseuse dans la leucémie myélomonocytaire chronique juvénile. Presse Med. 1988; 17: 2113–2116
   PubMedGoogle Scholar
• Palmer C.G., Provisor A.J., Weaver D.D., Hodes M.E., Heerema N. Juvenile chronic granulocytic leukemia in a patient with trisomy 8, neurofibromatosis, and prolonged Epstein-Barr virus infection. J. Pediatr. 1983; 102: 888–892
   PubMed Web of Science ®Google Scholar
• Stollmann B., Fonatsch C., Havers W. Persistent Epstein-Ban virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloprolif-erative disorders. Br. J. Haematol. 1985; 60: 183–196
   PubMed Web of Science ®Google Scholar
• Gürgey A., Rötig A., Gümrük F., Cemeroglu P., San-Alioglu F., Altay C. Pearson's marrow-pancreas syndrome in two Turkish children. Acta Haernatol 1992; 87: 206–209
   PubMed Web of Science ®Google Scholar
• Gilchrist D.M., Friedman J.M., Rogers P. C. J., Creighton S.P. Myelodysplasia and leukemia syndrome with monosomy 7: A genetic perspective. Am. J. Med. Genet. 1990; 35: 437–441
   PubMed Web of Science ®Google Scholar
• Paul B., Reid M.M., Davison E.V., Abela M., Hamilton P.J. Familial myelodysplasia: progressive disease associated with emergence of monosomy 7. Br. J. Haematol. 1987; 65: 321–323
   PubMed Web of Science ®Google Scholar
• Shannon K.M., Turhan A.G., Chang S. S. Y., Bow-Cock A.M., Rogers P. C. J., Carroll W.L., et al. Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7. J. Clin. Invest. 1989; 84: 984–989
   PubMed Web of Science ®Google Scholar
• Yabe H., Matsushita A., Ichiba S., Nagai K., Na-Kayama S. Myelodysplastic syndromes in two young brothers (Engl abstr). Rinsho Ketsueki 1992; 33: 184–188
   PubMedGoogle Scholar
• Lucas G.S., West R.R., Jacobs A. Familial myelodysplasia. Br. J. Med. 1989; 299: 551
   PubMed Web of Science ®Google Scholar
• Bain B. Down's syndrome—transient abnormal myelopoiesis and acute leukemia. Leukemia and Lymphoma 1991; 3: 309–317
   PubMed Web of Science ®Google Scholar
• Iselius L., Jacobs P., Morton N. Leukemia and transient leukemia in Down syndrome. Hum. Genet. 1990; 85: 477–485
   PubMed Web of Science ®Google Scholar
• Lie S.O., Berglund G., Gustafsson G., Jonmundsson G., Siimes M., Yssing M. High-dose Ara-C as a single agent consolidation therapy in childhood acute my elogenous leukemia. Hamatol. Bluttransfus. 1990; 33: 215–221
   Google Scholar
• Zipursky A., Doyle J., Christensen H., de Harven E. Myelodysplasia (MDS) and acute megakaryoblastic leukemia (AKML) in Down syndrome (abstr). Proc. AS-PHO 1992; 1: 12–13
   Google Scholar
• Kojima S., Matsuyama T., Sato T., Horibe K., Konishi S., Tsuchida M., et al. Down's syndrome and acute leukemia in children: An analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet per-oxidase reaction. Blood 1990; 76: 2348–2353
   PubMed Web of Science ®Google Scholar
• McMullin M.F., Mahendra P., Hain R., Barrett A.J. Myelodysplasia as the initial presentation of Fan-coni's anaemia in a phenotypically normal child. Clin. Lab. Haematol. 1991; 13: 387–389
   PubMedGoogle Scholar
• Standen G.R., Hughes I.A., Geddes A.D., Jones B.M., Wardrop C. A. J. Myelodysplastic syndrome with trisomy 8 in an adolescent with Fanconi anaemia and selective IgA deficiency. Am. J. Hematol. 1989; 31: 280–283
   PubMed Web of Science ®Google Scholar
• Gyger M., Perreault C., Belanger R., Bonny Y., Forest L., Lussier P. Unsuspected Fanconi's anemia and bone marrow transplantation in cases of acute myelomono-cytic leukemia. N. Engl. J. Med. 1989; 321: 120–121
   PubMed Web of Science ®Google Scholar
• Alter B.P. Leukemia and preleukemia in Fanconi's anemia. Cancer Genet. Cytogenet. 1992; 58: 206–208
   PubMed Web of Science ®Google Scholar
• Bader J.L., Miller R.W. Neurofibromatosis and childhood leukemia. J. Pediatr. 1978; 92: 925–929
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Maseki N., Sakurai M., Shibuya A., Shi-Nohara T., Fujimoto T., et al. Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibro matosis. Leukemia 1989; 3: 36–41
   PubMed Web of Science ®Google Scholar
• Kelleher J.F., Carbone T.V. Monosomy 7 syndrome in an infant with neurofibromatosis. Am. J. Pediatr. Hematol. Oncol. 1991; 13: 338–341
   PubMedGoogle Scholar
• Shannon K.M., Watterson J., Johnson P., O'Connell P., Lange B., Shah N., Steinherz P., Kan Y.W., Priest J.R. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type l: epidemiology and mo lecular analysis. Blood 1992; 79: 1311–1318
   PubMed Web of Science ®Google Scholar
• Woods W.G., Roloff J.S., Lukens J.N., Krivit W. The occurrence of leukemia in patients with the Shwachman syndrome. J. Pediatr. 1981; 99: 425–428
   PubMed Web of Science ®Google Scholar
• Feliú A., Bonduel M., Sciuccati M., Gorla N., Fundia A., Larripa I., et al. Bloom's syndrome, myelodys plasia, and unclassifiable acute leukemia (abstr). 24th Congr. Int. Soc. Haematol, London, August, 1992
   Google Scholar
• Kobrinsky N.L., Nesbit M.E., Ramsay N. K. C., Arthur D.C., Krivit W., Brunning R.D. He-matopoietic dysplasia and marrow hypocellularity in chil dren: a preleukemic condition. J. Pediatr. 1982; 100: 907–913
   PubMed Web of Science ®Google Scholar
• Hinoda Y., Itoh H., Takahashi T., Adachi M., Tsujisaki M., Imai K., Yachi A. Myelodysplastic syn drome in a patient with a unique constitutional chromosome abnormality t(2;ll) (q31;p13). Int. J. Hematol. 1992; 56: 95–97
   PubMed Web of Science ®Google Scholar
• Rubin C.M., Arthur D.C., Woods W.G., Lange B.J., Nowell P.C., Rowley J.D., et al. Therapy-related myelodysplastic syndrome and acutemyeloid leukemia in children: Correlation between chromosomal abnormalities and prior therapy. Blood 1991; 78: 2982–2988
   PubMed Web of Science ®Google Scholar
• Aul C., Gattermann N., Schneider W. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br. J. Haernatol. 1992; 82: 358–367
   PubMed Web of Science ®Google Scholar
• Reizenstein P., Dabrowski L. Increasing prevalence of the myelodysplastic syndrome. An international delphistudy. Anticancer Res. 1991; 11: 1069–1070
   PubMed Web of Science ®Google Scholar
• Foucar K., Langdon R.M., Armitage J.O., Olson D., Carroll T.J. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases. Cancer 1985; 56: 553–561
   PubMed Web of Science ®Google Scholar
• Groupe FranGais de Morphologie Htmatologique. French registry of acute leukemia and myelodysplastic syndromes. Cancer 1987; 60: 1385–1394
   PubMedGoogle Scholar
• Jackson G.H., Carey P.J., Cant A.J., Bown N.P., Reid M.M. Myelodysplastic syndromes in children. Br. J. Haematol. 1993; 84: 185–186
   PubMed Web of Science ®Google Scholar
• Blank J., Lange B. Preleukemia in children. J. Pediatr. 1981; 98: 565–568
   PubMed Web of Science ®Google Scholar
• Gutjahr P. Hhatopcetische dysplasie—Präleukämie. Kinderarzt 1984; 15: 1564–1565
   Google Scholar
• Niebrugge D.J. Preleukemia in children. J. Pe diatr. 1982; 100: 507
   PubMed Web of Science ®Google Scholar
• Lübbert M., Mirro J., Kitchingman G., McCormick F., Mertelsmann R., Herrmann F., Koeffler H.P. Prevalence of N-ras mutations in children with myelodys plastic syndromes and acute myeloid leukemia. Oncogene 1992; 7: 263–268
   PubMed Web of Science ®Google Scholar
• Solé F., Prieto F., Badia L., Woessner S., Florensa L., Caballin M.R., Coll M.D., et al. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genet. Cytogenet. 1992; 64: 12–20
   PubMed Web of Science ®Google Scholar
• Hazani A., Barak Y., Berant M., Bar-Maor A. Congenital juvenile chronic myelogenous leukemia: Thera peutic trial with interferon alpha-2. Med. Pediatr. Oncol. 1993; 21: 73–76
   PubMedGoogle Scholar
• McMullin M.F., Chrisholm M., Hows J.M. Congenital myelodysplasia: A newly described disease entity?. Br. J. Haematol. 1991; 79: 340–342
   PubMed Web of Science ®Google Scholar
• O'Donnell M.R., Nademanee A.P., Snyder D.S., Schmidt G.M., Parker P.M., Bierman P.J., et al. Bone marrow transplantation for myelodysplastic and my-eloproliferative syndromes. J. Clin. Oncol. 1987; 5: 1822–1826
   PubMed Web of Science ®Google Scholar
• Bader-Meunier B., Thollot F., Mielot F., Yvart J., Dom-Mergues J.P., Sommelet D., Tchernia G. Myélodysplasies régressive de I'enfant. Arch. Fr. Pediatr. 1992; 49: 883–886
   PubMedGoogle Scholar
• Castañeda V.L., Williams T.E., Harper J.L., Graham Pole J., Parmley R.T. Severe refractory anemia with ringed sideroblasts and bone marrow aplasia in a child. Am. J. Pediatr. Hematol. Oncol. 1992; 14: 70–76
   PubMedGoogle Scholar
• Geschke W., Beutler E. Refractory sideroblastic and nonsideroblastic anemia. West J. Med. 1977; 127: 85–92
   PubMedGoogle Scholar
• Kalwinsky D.K., Raimondi S.C., Schell M.L., Mirro J., Santana V.M., Behm F., et al. Prognostic im portance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J. Clin. Oncol. 1990; 8: 75–83
   PubMed Web of Science ®Google Scholar
• Geddes A.D., Bowen D.T., Jacobs A. Clonal karyotype abnormalities and clinical progress in the myelo dysplastic syndrome. Br. J. Haematol. 1990; 76: 194–202
   PubMed Web of Science ®Google Scholar
• Van den Berghe H. The 5q- syndrome. Scand. J. Haematol. 1986; 36(Suppl. 45)78–81
   Google Scholar
• Uyttebroeck A., de Groote B., Renard M., Brock P., Dal Cin P., van den Berghe H., Casteels-van Daele M. The occurrence of 5q-syndrome in a child (abstr). Med. Pediatr. Oncol. 1992; 20: 465
   Google Scholar
• Shikano T., Ishikawa Y., Anakura M. Myelo dysplastic syndrome with partial deletion of the long arm of chromosome 5: first report of a case in a child. Acta Pae-diatr. Jpn. 1992; 34: 539–542
   PubMedGoogle Scholar
• Bagby G.C., Gabourel J.D., Linman J.W. Glucocorticoid therapy in preleukemic syndrome (hemopoi-etic dysplasia). Ann, Intern. Med. 1980; 92: 55–58
   PubMed Web of Science ®Google Scholar
• Motoji T., Teramura M., Takahashi M., Oshimi K., Okada M., Kusakabe K., Mizoguchi H. Successful treatment of refractory anaemia with high-dose meth-ylprednisolone. Am. J. Hematol. 1990; 33: 8–12
   PubMed Web of Science ®Google Scholar
• Muller E.M., de Wolf J.T., Vellenga E. Successful immunosuppressive treatment after failure of eryth-ropoietin therapy in two subjects with refractory anaemia. Br. J. Haematol. 1993; 83: 171–172
   PubMed Web of Science ®Google Scholar
• Yoshida Y. Japanese experience in the treatment of myelodysplastic syndromes. Hematol. Oncol. Clin. North Am. 1992; 6: 673–685
   PubMed Web of Science ®Google Scholar
• Narayanan M.N., Benaim M.E., Geary C.G., Harrison C.J. Hyperfibrotic myelodysplasia. Br. J. Haematol. 1991; 79: 653–659
   PubMed Web of Science ®Google Scholar
• Nagler A., Hazani A., Etzioni A., Tatarsky I. Disturbances of T lymphocyte subsets preceding refractory anemia with excess blasts in transformation in a child. Acta Haematol. 1988; 79: 103–106
   PubMed Web of Science ®Google Scholar
• Sulecki M., Shadduck R.K., Zeigler Z. Anti-thymocyte globulin for hypoplastic myelodysplastic syn drome (abstr). Blood 1988; 72: 229a
   Google Scholar
• Tichelli A., Gratwohl A., Wuersch A., Nissen C., Speck B. Antilymphocyte globulin for myelodys plastic syndrome?. Br. J. Haematol. 1988; 68: 139–140
   PubMed Web of Science ®Google Scholar
• Litzow M.R., Kyle R.A. Multiple responses of aplastic anemia to low-dose cyclosporine therapy despite development of a myelodysplastic syndrome. Am. J. He matol. 1989; 32: 226–229
   PubMed Web of Science ®Google Scholar
• Riccardi A.M., Giordano M., Girino M., Cazzola M., Montecucco C.M., Cassano E., et al. Refractory cytopenia: Clinical course according to bone marrow cytology and cellularity. Blut 1987; 54: 153–163
   PubMedGoogle Scholar
• Selleri C., Catalano L., DeRosa G., Fontana R., Notaro R., Rotoli B. Danazol: in vitro effect on human hemopoiesis and in vitro activity in hypoplastic and myelo dysplastic disorders. Eur. J. Haematol. 1991; 47: 197–203
   PubMed Web of Science ®Google Scholar
• Stadtmauer E.A., Cassileth P.A., Edelstein M., Abra ham J., Schreiber A.D., Nowell P.C., Cines D.B. Danazol treatment of myelodysplastic syndromes. Br. J. Haematol. 1991; 77: 502–508
   PubMed Web of Science ®Google Scholar
• Kizaki M., Koeffler H.P. Differentiation-in ducing agents in the treatment of myelodysplastic syn dromes. Semin. Oncol. 1992; 19: 95–105
   PubMed Web of Science ®Google Scholar
• Paquette R.L., Koeffler H.P. Differentiation therapy. Hematol. Oncol. Clin. North Am. 1992; 6: 687–706
   PubMed Web of Science ®Google Scholar
• De Rosa L., Montuoro A., De Laurenzi A. Therapy of ‘high risk’ myelodysplastic syndromes with an association of low-dose Ara-C, retinoic acid and 1,25-dihy-droxyvitamin D3. Biomed. Pharmacother. 1992; 46: 211–217
   PubMed Web of Science ®Google Scholar
• Castleberry R.P., Emanuel P., Gualtieri R., Zuckerman K., Cohn S., Straws L., et al. Preliminary experience with 13-cis retinoic acid in the treatment of JCML (abstr). Blood 1991; 78: 170a
   Google Scholar
• Emanuel P.D., Zuckerman K.S., Wimmer R., Cohn S., Chaffee S., Castleberry R.P. In vivo 13-cis-retinoic acid therapy decreases the in vitro GM-CSF hy-persensitivity in JCML (abstr). Blood 1991; 78: 170a
   Google Scholar
• Mutz I.D., Zoubek A. Transient response to alpha-interferon in juvenile chronic myelomonocytic leukemia. Pediatr. Hematol. Oncol. 1988; 5: 71–75
   PubMed Web of Science ®Google Scholar
• Pechumer H., Bender-Götze C., Walther J.U., Klinge-Biel T., Ehninger G., Suttorp M., Schmitz N. Juvenile chronische Leukamie und chronische) myelornono- zytare Leukamie. Erfahrungen mitder Knochenmarktran-splantat. Monatsschr. Kinderheilkd. 1992; 140: 307–312
   PubMedGoogle Scholar
• Aul C., Gattermann N., Schneider W. Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha 2b. Eur. J. Haematol. 1991; 46: 11–16
   PubMed Web of Science ®Google Scholar
• Nand S., Ellis T., Messmore H., Fisher S.G., Gaynor E., Fisher R.I. Phase II trial of recombinant human interferon alpha in myelodysplastic syndromes. Leukemia 1992; 6: 220–223
   PubMed Web of Science ®Google Scholar
• Adamson J.W., Schuster M., Allen S., Haley N.R. Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes. Acta Haematol. 1992; 87(Suppl. l)20–24
   PubMedGoogle Scholar
• Stein R.S., Abels R.I., Krantz S.B. Phar-macologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood 1991; 78: 1658–1663
   PubMed Web of Science ®Google Scholar
• Van Kamp H., Prinsze-Postema T.C., Kluin P.M., den Ottolander G.J., Beverstock G.C., Willemze R., Fibbe W.E. Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia. Br. J. Haematol. 1991; 78: 188–193
   Google Scholar
• Verhoef G.E., Zachee P., Ferrant A., Demuynck H., Selleslag D., Van Hove L., et al. Recombinant human erythropoietin for the treatment of anemia in the my elodysplastic syndromes: a clinical and erythrokinetic as sessment. Ann. Hematol. 1992; 64: 16–21
   PubMed Web of Science ®Google Scholar
• Ganser A., Seipelt G., Eder M., Geissler G., Ottmann O.G., Hess U., Hoelzer D. Treatment of my elodysplastic syndromes with cytokines and cytotoxic drugs. Semin. Oncol. 1992; 19(Suppl. 4)95–101
   PubMedGoogle Scholar
• Willemze R., van der Lely N., Zwierzina H., Suciu S., Solbu G., Gerhartz H., et al. A randomized phase I/II multicenter study of recombinant GM-CSF therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. Ann. Hematol. 1992; 64: 173–180
   PubMed Web of Science ®Google Scholar
• Ganser A., Völkers B., Greher J., Ottmann O.G., Becher R., Bergman L., et al. Recombinant human granu-locyte-macrophage colony stimulating factor in patients with myelodysplastic syndromes—A phase I/II trial. Blood 1989; 73: 31–37
   PubMed Web of Science ®Google Scholar
• Kojima S., Tsuchida M., Matsuyama T. My elodysplasia and leukemia after treatment of aplastic anemia with G-CSF. N. Engl. J. Med. 1992; 326: 1294–1295
   PubMed Web of Science ®Google Scholar
• Schuster M.W., Thompson J.A., Larson R., Allen S.L., O'Laughlin R., Israel R., Fefer A. Ran domized trial of subcutaneous GM-CSF versus observation in patients with MDS (abstr). J. Cancer Res. Clin. Oncol. 1990; 116: 1079
   Google Scholar
• Ganser A., Ottmann O.G., Hoelzer D. Inter-leukin-3 in the treatment of myelodysplastic syndromes. Int. J. Clin. Lab. Res. 1992; 22: 125–128
   PubMedGoogle Scholar
• Kurzrock R., Talpaz M., Estrov Z., Rosenblum M.G., Gutterman J.U. Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. J. Clin. Oncol. 1991; 9: 1241–1250
   PubMed Web of Science ®Google Scholar
• Estrov Z., Kurzrock R., Talpaz Blake M., Gutter-Man J.U. Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: a potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro. Ann. Hematol. 1991; 63: 297–301
   PubMed Web of Science ®Google Scholar
• Suttorp M., Schmitz N., Prange E., Oster W., Löffler H., Schaub J., Ganser A. Remission of juvenile chronic myeloid leukemia following graft failure of an un related marrow transplant and autologous recovery of mar row function promoted by GM-CSF and IL-3. Leukemia 1991; 8: 723–725
   Google Scholar
• Leverger G., Valensi F., Daniel M.T., Schaison G., Bancillon A., Castaigne S. Efficacité de la cytarabine à faible doses après échec d'une chimiothérapie conventionelle. Presse Med. 1985; 14: 1562
   PubMedGoogle Scholar
• Reman O., Boutard P., Guihard J. Efficacy of low-dose Aracytine in 3 cases of refractory anemia in trans formation in children. Now. Rev. Fr. Hematol. 1988; 30: 243–246
   PubMedGoogle Scholar
• Lu J.-C., Lin M.-T., Lai I.-H., Su I.-J. My elodysplastic syndrome in childhood: Report of a case. Acta Paed. Sin. 1988; 29: 192–195
   Google Scholar
• Appelbaum F.R., Storb R., Ramberg R.E., Shulman H.M., Buckner C.D., Clift R.A., et al. Treatment of preleukemic syndromes with marrow transplantation. Blood 1987; 69: 92–96
   PubMed Web of Science ®Google Scholar
• Berndt M.C., Kabral A., Grimsley P., Watson N., Robertson T.L., Bradstock K.F. An acquired Ber-nard-Soulier-like platelet defect associated with juvenile my elodysplastic syndrome. Br. J. Haematol. 1988; 68: 97–101
   PubMed Web of Science ®Google Scholar
• Miller B.A., Weinstein H.J., Nell M., Henkle C.T., Dillon P.L., Tantravahi R. Sequential development of distinct clonal chromosome abnormalities in a patient with preleukaemia. Br. J. Haematol. 1985; 59: 411–418
   PubMed Web of Science ®Google Scholar
• Hellström-Lindberg E., Robert K.H., Gahcon G., Lind-Berg G., Forsblom A.M., Kock Y., Öst A. A predictive model for the clinical response to low dose ara-C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia. Br. J. Haematol. 1992; 81: 503–511
   PubMed Web of Science ®Google Scholar
• Miller K.B., Kim K., Morrison E.S., Winter J.N., Bennett J.M., Neiman R.S., et al. The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study. Ann. Hematol. 1992; 65: 162–168
   PubMed Web of Science ®Google Scholar
• Michels S.D., Saumur J., Arthur D.C., Robinson L.L., Brunning R.D. Refractory anemia with excess of blasts in transformation. Hematologic and clinical study of 52 patients. Cancer 1989; 64: 2340–2346
   PubMed Web of Science ®Google Scholar
• Franés M. A. P., Gutiérrez A.N., Woessner S., Cald-erón E.M., Regato J. L. B. Síndrome mielodis-plástico evolucionado a leucemia aguda eritromegaca-rioblática. A propósito de un caso pediátrico. An. Esp. Pediatr. 1988; 29(Suppl. 134)150–153
   Google Scholar
• Moir D.J., Jones P. A. E., Pearson J., Duncan J.R., Cook P., Buckle V.J. A new translocation, t(1;3)(p36;q21), in myelodysplastic disorders. Blood 1984; 64: 553–555
   PubMed Web of Science ®Google Scholar
• Ravindranath Y., Abella E., Krischer J.P., Wiley J., Inoue S., Harris M., et al. AML in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood 1992; 80: 2210–2214
   PubMed Web of Science ®Google Scholar
• Chan H. S. L., Estrov Z., Weitzman S.S., Freedman M.H. The value of intensive combination chemo therapy for juvenile chronic myelogenous leukemia. J. Clin. Oncol. 1987; 5: 1960–1967
   PubMed Web of Science ®Google Scholar
• Festa R.S., Shende A., Lanzkowsky P. Juvenile chronic myelocytic leukemia: Experience with intensive combination chemotherapy. Med. Pediatr. Oncol. 1990; 18: 311–316
   PubMedGoogle Scholar
• De Witte T., Muus P., De Pauw B., Haanen C. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer 1990; 66: 831–837
   PubMed Web of Science ®Google Scholar
• Fenaux P., Morel P., Rose C., Lai J.L., Jouet J.P., Bauters F. Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy. Br. J. Haematol. 1991; 77: 497–501
   PubMed Web of Science ®Google Scholar
• Tricot G., Boogaerts M.A. The role of aggressive chemotherapy in the treatment of the myelodys plastic syndromes. Br. J. Haematol. 1986; 63: 477–483
   PubMed Web of Science ®Google Scholar
• Gajewski J.L., Ho W.G., Nimer S.D., Hirji K.F., Gekelman L., Jacobs A.D., Champlin R.E. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome. J. Clin. Oncol. 1989; 7: 1637–1645
   PubMed Web of Science ®Google Scholar
• Martiat P., Ferrant A., Michaux J.J., Sokal G. Intensive chemotherapy for acute non-lymphoblastic leukemia after primary myelodysplastic syndrome. Hematol. On Col. 1988; 6: 299–305
   Google Scholar
• Gamer A., Heil G., Kolbe K., Maschmeyer G., Fischer J.T., Bergmann L., et al. Aggressive chemotherapy combined with G-CSF and maintenance therapy with inter-leukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia—initial results. Ann. Hematol. 1993; 66: 123–125
   PubMed Web of Science ®Google Scholar
• Sanders J.E., Buckner C.D., Stewart P., Thomas E.D. Successful treatment of juvenile chronic granulocytic leukemia with marrow transplantation. Pediatrics 1979; 63: 44–46
   PubMed Web of Science ®Google Scholar
• Sanders J.E., Buckner C.D., Thomas E.D., Fleischer R., Sullivan K.M., Appelbaum F.A., Storb R. Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 1988; 71: 1144–1146
   PubMed Web of Science ®Google Scholar
• Bélanger R., Gyger M., Perreault C., Bonny Y., St-Louis J. Bone marrow transplantation for myelodysplastic syndromes. Br. J. Haematol. 1988; 69: 29–33
   PubMed Web of Science ®Google Scholar
• Bunin N.J., Casper J.T., Chitambar C., Hunter J., Truitt R., Menitove J., et al. Partially matched bone mar row transplantation in patients with myelodysplastic syndromes. J. Clin. Oncol. 1988; 6: 1851–1855
   PubMed Web of Science ®Google Scholar
• Guinan E.C., Tarbell N.J., Tantravahi R., Wein-Stein H.J. Bone marrow transplantation for children with myelodysplastic syndromes. Blood 1989; 73: 619–622
   PubMed Web of Science ®Google Scholar
• Longmore G., Guinan E.C., Weinstein H.J., Gelber R.D., Rappeport I.M., Antin J.H. Bone marrow transplantation for myelodysplasia and secondary acute non-lymphoblastic leukemia. J. Clin. Oncol. 1990; 8: 1707–1714
   PubMed Web of Science ®Google Scholar
• Massaad L., Prieur M., Leonard C., Dutrillaux B. Biclonal chromosome evolution of chronic myelo-monocytic leukemia in a child. Cancer Genet. Cytogenet. 1990; 44: 131–137
   PubMed Web of Science ®Google Scholar
• Uderzo C., Locasciulli A., Cantú-Rajnoldi A., Mozzana R., Lambertenghi-Deliliers G., Masera G. Al logeneic bone marrow transplantation for myelodysplastic syndromes of childhood: Report of three children with refractory anemia with excess of blasts in transformation and review of the literature. Med. Pediatr. Oncol. 1993; 21: 43–48
   PubMedGoogle Scholar
• Kernan N.A., Bartsch G., Ash R.C., Beatty P.G., Champlin R., Filipovich A., et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N. Engl. J. Med. 1993; 328: 593–602
   PubMed Web of Science ®Google Scholar
• Nevill T.J., Shepherd J.D., Reece D.E., Barnett M.J., Nantel S.H., Klingemann H.G., Phillips G.L. Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT. Bone Marrow Transplant 1992; 10: 445–450
   PubMed Web of Science ®Google Scholar
• Urban C., Schwinger W., Slavc I., Scmid C., Gam-Illscheg A., Lackner H., et al. Busulfan/cyclo-phosphamide plus bone marrow transplantation is not sufficient to eradicate the malignant clone in juvenile chronic myelogenous leukemia. Bone Marrow Transplant 1990; 5: 353–356
   PubMed Web of Science ®Google Scholar
• Appelbaum F.R., Barrall J., Storb R., Fisher L.D., Schoch G., Ramberg R.E., et al. Bone marrow transplantation for patients with myelodysplasia. Ann. Intern. Med. 1990; 112: 590–597
   PubMed Web of Science ®Google Scholar
• De Witte T., Zwaan F., Hermans J., Vernant J., Kolb H., Vossen J., et al. Allogeneic bone marrow trans plantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). Br. J. Haematol. 1990; 74: 151–155
   PubMed Web of Science ®Google Scholar
• Sutton L., Leblond V., Le Maignan C., Jouet J.P., Kuentz M., Gluckman E., et al. Bone marrow trans plantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients (abstr). Bone Marrow Trans plant 1991; 7(Suppl. 2)39
   PubMedGoogle Scholar
• Emmerson A.J., Grace R.J., Grech H., Stem C.M., Pearson T.C. Haematological improvement with conservative management in an infant with myelodysplasia. J. R. Soc. Med. 1992; 85: 495–496
   PubMed Web of Science ®Google Scholar
• Penchansky L., Wollman M.R., Gartner J.C., Wen-Ger S. Spontaneous remission of infantile acute non-lymphocytic leukemia for 11 years in a child with normal karyotype. Cancer 1993; 71: 1928–1930
   PubMed Web of Science ®Google Scholar
• Broun E.R., Heerema N.A., Tricot G. Spontaneous remission in myelodysplastic syndrome. A case report. Cancer Genet. Cytogenet. 1990; 46: 125–130
   PubMed Web of Science ®Google Scholar
• Yoshida Y., Oguma S., Uchino H., Maekawa T., Nomura T. Clinical features of long-term survivors of refractory myelodysplastic anemias. A Japanese cooperative study. Leuk. Res. 1992; 16: 775–779
   PubMed Web of Science ®Google Scholar